Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02123498

The Study of Eustachian Tube Dysfunction and Laryngopharyngeal Reflux

The Study of the Diagnosis of Eustachian Tube Dysfunction (ETD): Identifying the Relationship of Ear Fullness to Laryngopharyngeal Reflux (LPR)

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Loma Linda University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate the relationship between ear fullness, pressure, and/or pain and laryngopharyngeal reflux, in order to focus medical therapy and improve therapeutic outcomes in this patient population.

Conditions

Interventions

TypeNameDescription
DRUGOmeprazole40mg, to be taken once daily by mouth, 30-60 minutes before meals, for at least 6 weeks
DRUGRanitidine300mg, to be taken once daily by mouth, before bedtime, for at least 6 weeks
DRUGPantoprazole40mg, to be taken twice daily by mouth, 30-60 minutes before meals, for at least 6 weeks. (Alternative intervention if participant cannot tolerate omeprazole, is on an anticoagulant medication, or if on medication contraindicated for omeprazole and ranitidine)
PROCEDURE24-Hour Diagnostic pH-Probe TestParticipants will undergo a routine clinical 24-hour diagnostic pH-probe test to assess quantitative measures for laryngopharyngeal reflux.
PROCEDURELaryngoscopyParticipants will undergo routine clinical laryngoscopy to assess presence of laryngopharyngeal reflux.

Timeline

Primary completion
2015-05-01
First posted
2014-04-25
Last updated
2016-09-26

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02123498. Inclusion in this directory is not an endorsement.